Cernostics, a Pittsburgh, PA-based diagnostics company focused on delivering better cancer diagnosis and prognosis through a unique approach to tissue analysis has raised $2.5 million in Series A funding led by Illumina Ventures. With the recent investment from Illumina Ventures, Cernostics has raised a total of $13 million, including investments from UPMC Enterprises, Novitas Capital, Geisinger Health System, the Pittsburgh Life Sciences Greenhouse, and Ben Franklin Technology Partners of
Read More
Cancer Diagnostics
Zebra Medical Vision Unveils AI-based Algorithm to Detect Brain Bleeds
Zebra Medical Vision, the machine and deep learning company that is creating the next generation services for the healthcare industry. In the past two years Zebra-Med launched different algorithms on a monthly basis to better diagnose breast cancer, heart attacks, and other life-threatening diseases, and now the company is officially releasing the first ever algorithm to detect brain bleeds. This algorithm has just been granted CE approval. The timely detection of brain bleeds is critical to a
Read More
University of Michigan, Tempus Partner on Personalized Breast Cancer Medicine Initiative
Breast cancer is the most common non-skin cancer and the second leading cause of cancer-related death in women. In 2017, it is estimated that more than 250,000 U.S. women will be diagnosed with new cases of invasive breast cancer. That’s why the University of Michigan Comprehensive Cancer Center has partnered with Tempus on a personalized cancer medicine initiative aimed providing most effective care for individuals diagnosed with breast cancer.As part of the initiative, Tempus will use
Read More
Backed by UPMC, Cancer Diagnostics Startup Cernostics Lands $5M
Cernostics, a Pittsburgh, PA-based cancer diagnostics startup has raised $5 million in funding led by UPMC Enterprises, UPMC's venture capital arm with participation from Novitas Capital. The company plans to utilize the funding to accelerate the introduction of new diagnostic test for people with an esophageal condition called Barrett’s Esophagus that can lead to cancer. The latest round brings the company's total funding to date to $12.4M. Founded in 2008, Cernostics is an oncology diagnostics
Read More
